Literature DB >> 20679932

Acute intraprocedural thrombus formation during wingspan intracranial stent placement for intracranial atherosclerotic disease.

Matthew F Lawson1, Gregory L Fautheree, Michael F Waters, David A Decker, J D Mocco, Brian L Hoh.   

Abstract

BACKGROUND: Treatment of intracranial atherosclerotic disease with the Wingspan-Gateway intracranial stent and balloon angioplasty system has been reported in several multicenter registries. To date, the incidence of acute intraprocedural thrombus formation during Wingspan stent placement has not been reported.
OBJECTIVE: We reviewed the incidence of acute thrombus formation, treatment, and outcome for patients who underwent Wingspan stent placement by the senior author (B.L.H.) between June 2006 and April 2009.
METHODS: We routinely perform angiograms every 10 minutes for at least 30 minutes after placement of a Wingspan stent to check for acute thrombus formation. Acute thrombus was graded: (1) visible thrombus but not flow limiting, (2) visible and flow-limiting thrombosis, and (3) complete stent occlusion. Recanalization was graded according to Thrombosis In Myocardial Infarction score.
RESULTS: Forty-one patients underwent Wingspan stent placement for intracranial stenosis. Acute intraprocedural thrombus formation developed in 6 (14.6%) within 20 minutes after stent placement: 3 grade 1, 1 grade 2, and 2 grade 3. All 6 were successfully recanalized with Thrombosis In Myocardial Infarction score 3 after intravenous abciximab with or without intra-arterial tissue plasminogen activator and/or balloon angioplasty. There was no morbidity, and all 6 patients were discharged home at their neurological baseline.
CONCLUSION: We recommend serial angiography every 10 minutes for at least 30 minutes after placement of Wingspan stents. Once detected, acute thrombosis can be successfully treated with intravenous abciximab with or without intra-arterial tissue plasminogen activator and/or balloon angioplasty.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20679932     DOI: 10.1227/01.NEU.0000380948.85926.3C

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  5 in total

1.  Coincidental Occurrence of Acute In-stent Thrombosis and Iatrogenic Vessel Perforation During a Wingspan Stent Placement: Management with a Stent In-stent Technique.

Authors:  Sun Joo Lee; Hee Sup Shin; Seung Hwan Lee; Jun Seok Koh
Journal:  Neurointervention       Date:  2012-02-29

2.  Factors Influencing the Outcome of Symptomatic Intracranial Artery Stenosis With Hemodynamic Impairment After Short and Long-Term Stent Placement.

Authors:  Wentao Gong; Xianjun Zhang; Zhen Meng; Feifei Liu; Guangwen Li; Juan Xiao; Peng Liu; Yujie Sun; Tonghui Liu; Hongxia Wang; Yong Zhang; Naidong Wang
Journal:  Front Neurol       Date:  2022-05-17       Impact factor: 4.086

Review 3.  2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials.

Authors:  Mayank Goyal; Kyle M Fargen; Aquilla S Turk; J Mocco; David S Liebeskind; Donald Frei; Andrew M Demchuk
Journal:  J Neurointerv Surg       Date:  2013-02-06       Impact factor: 5.836

4.  Safety and Efficacy of Tirofiban in Rescue Treatment for Acute Intracranial Intraprocedural Stent Thrombosis.

Authors:  Lili Sun; Jinping Zhang; Yun Song; Wei Zhao; Meimei Zheng; Jun Zhang; Hao Yin; Wei Wang; Yao Meng; Jiyou Tang; Ju Han
Journal:  Front Neurol       Date:  2020-06-16       Impact factor: 4.003

5.  Safety and efficacy of prophylactic tirofiban infusion for acute intracranial intraprocedural stent thrombosis.

Authors:  Lili Sun; Jinping Zhang; Yun Song; Wei Zhao; Meimei Zheng; Jun Zhang; Hao Yin; Wei Wang; Yao Meng; Ju Han
Journal:  Sci Rep       Date:  2021-10-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.